Compare Merdeka Gold Resources Tbk. (EMAS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merdeka Gold Resources Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Merdeka Gold Resources Tbk. trades at Rp5,725 (market cap 84.34T), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B). The key difference: Merdeka Gold Resources Tbk. is far larger — about 503.9× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.
| EMAS | OBAT | |
|---|---|---|
Market Cap | 84.34T | 167.37B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merdeka Gold Resources Tbk.
PT Merdeka Gold Resources Tbk (formerly PT Pani Bersama Jaya) (the Company), was established in Republic of Indonesia based on Deed of Establishment No. 87 dated 20 November 2015 made before Humberg Lie, S.H., S.E., M.Kn., Notary in North Jakarta. The ultimate parent entity of the Company is PT Merdeka Copper Gold Tbk (MCG). Meanwhile, MCG is jointly controlled by PT Provident Capital Indonesia and PT Saratoga Investama Sedaya Tbk, which are respectively controlled by Winato Kartono and Edwin Soeryadjaya.
Read more on EMAS →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
